भारत की Pharma Industry में एक बड़ा झूठ छुपा है… क्या ? जानिए इधर with Amit Choudhary

India’s pharmaceutical industry is undergoing rapid transformation, and in a recent Face2Face episode with Vivek Bajaj, entrepreneur Amit Choudhary shed light on this evolving landscape. He emphasized how generic medicines are driving growth by offering affordable yet effective alternatives, especially in rural and semi-urban regions. The stark price difference between branded and generic drugs highlights the industry's unique challenges and opportunities—balancing accessibility with profitability.

Amit also touched on the shift towards ethical practices, with the government tightening regulations around doctor incentives and ensuring more transparency. His journey as an MSME founder illustrates how data-driven decisions, compliance, and long-term value creation are becoming essential in building sustainable pharma businesses. With ongoing innovation and greater focus on affordability, India’s pharma sector is well-positioned for responsible and significant growth.